|
|
 |
|
|
| Safinamide mesylate |
| Manus Aktteva offers Safinamide mesylate, 202825-46-5,133865-89-1, for your RND and its intermediates, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
|
| Product Reference ID: MA-BB-496-O |
|
|
| Chemical Name: |
Safinamide mesylate, 2(S)-[4-(3-Fluorobenzyloxy)benzylamino]propionamide mesylate |
|
|
| Description |
| CAS number |
202825-46-5, 133865-89-1 |
| Synonym |
Safinamide mesylate, 2(S)-[4-(3-Fluorobenzyloxy)benzylamino]propionamide mesylate |
| Molecular Formula |
C17H19FN2O2 |
| Packing |
Technical Package available |
Material Safety Data Sheet
|
Available
|
| Availability |
RND & Evaluation |
|
|
|
|
|
|
 Are you looking for Safinamide mesylate Intermediates ? Please click here to browse through the list of Safinamide mesylate Intermediates available with us. |
|
| Safinamide mesylate, 202825-46-5,133865-89-1, manufacturers, suppliers, India, china |
|
|
|
|
 |
NOTE: 
- Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|